Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States

NCT03952364 is registered in ClinicalTrials.gov with PredictImmune Ltd as lead sponsor.

NCT NCT03952364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03952364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PRECIOUS Study: Predicting Crohn's & ColitIs Outcomes in the United States
Lead sponsor
PredictImmune Ltd
Phase
Observational
Overall status
Unknown status
Start date
October 10, 2019
Completion date
June 30, 2022
Enrollment
200 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ibd, inflammatory bowel diseases, ulcerative colitis